Docetaxel rechallenge in castration-resistant prostate cancer: scientific legitimacy of common clinical practice

Eur Urol. 2010 Oct;58(4):636-7. doi: 10.1016/j.eururo.2010.06.025. Epub 2010 Jun 23.

Authors

Carlo Buonerba, Giovannella Palmieri, Giuseppe Di Lorenzo

PMID: 20580484
DOI: 10.1016/j.eururo.2010.06.025

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Agents / therapeutic use*
Docetaxel
Evidence-Based Medicine
Humans
Male
Prostatic Neoplasms / drug therapy*
Taxoids / therapeutic use*
Treatment Failure

Substances

Antineoplastic Agents
Taxoids
Docetaxel